LEADER 03678nam  22005895  450 
001 9910633930303321
005 20230810230053.0
010   $a9783658389314$b(electronic bk.)
010   $z9783658389307
024 7 $a10.1007/978-3-658-38931-4
035   $a(MiAaPQ)EBC7151620
035   $a(Au-PeEL)EBL7151620
035   $a(CKB)25554161300041
035   $a(DE-He213)978-3-658-38931-4
035   $a(EXLCZ)9925554161300041
100   $a20221202d2023      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCOVID-19: Search for a vaccine /$fby Patric U. B. Vogel
205   $a1st ed. 2023.
210  1$aWiesbaden :$cSpringer Fachmedien Wiesbaden :$cImprint: Springer Spektrum,$d2023.
215   $a1 online resource (60 pages)
225 1 $aessentials,$x2197-6716
311 08$aPrint version: Vogel, Patric U. B. COVID-19: Search for a Vaccine Wiesbaden : Springer Fachmedien Wiesbaden GmbH,c2023 9783658389307 
327   $aIntroduction -- Coronaviruses: history and viral properties -- Vaccine technologies, approaches against COVID-19, clinical phases -- Attenuated live vaccines -- Vector vaccines and virus-like particles -- Inactivated vaccines -- Recombinant proteins (protein subunits) -- Nucleic acid-based vaccines -- Other aspects - One vaccine for all? - Herd immunity - Duration of immunity - Sterilizing immunity -- Summary.
330   $aThis book presents the principle, strengths and weaknesses, and progress of various vaccine technologies against COVID-19. Additionally, important terms such as clinical phases, efficacy and sterilizing immunity are explained. In this second edition, the already approved vaccines are also presented and the importance of viral variants is explained. The content An introduction to the principle of vaccine technologies and their strengths and weaknesses The presentation of successes and failures of vaccines An overview of the currently ongoing vaccine projects against COVID-19 The target groups People with an interest in vaccines, viruses or infectious diseases People who want to better understand the current press releases on COVID-19 vaccine development. The author Patric U. B. Vogel is a biologist with many years of experience with various biopharmaceuticals, from live vaccines to DNA vaccines. He was a registered Qualified Person for several years and has regularly released coronavirus vaccines against animal diseases, among other things. Since 2019, he has been an author, trainer and consultant in the pharmaceutical field. This book is a translation of an original German edition. The translation was done with the help of artificial intelligence (machine translation by the service DeepL.com). A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation.
410  0$aessentials,$x2197-6716
606   $aVaccines$xBiotechnology
606   $aBiomaterials
606   $aPharmacy
606   $aPharmaceutical chemistry
606   $aBiomaterials-Vaccines
606   $aPharmacy
606   $aMedicinal Chemistry
615  0$aVaccines$xBiotechnology.
615  0$aBiomaterials.
615  0$aPharmacy.
615  0$aPharmaceutical chemistry.
615 14$aBiomaterials-Vaccines.
615 24$aPharmacy.
615 24$aMedicinal Chemistry.
676   $a362.1962414
700   $aVogel$b Patric U. B.$01271396
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
912   $a9910633930303321
996   $aCOVID-19$92995184
997   $aUNINA